Certain weight loss and diabetes medications, including tirzepatide (Zepbound, Mounjaro) and semaglutide (Ozempic, Wegovy), may help people sleep better. This is because losing weight can ease symptoms of sleep apnea, which can then result in a more restful night.
Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content.This is because losing weight can ease symptoms of sleep apnea, which can then result in a more restful night.
On Wednesday, the company released results from two clinical trials, both of which compared tirzepatide use to a placebo over the course of a year. “I knew when my weight went up, so did my snoring, but I didn’t anticipate that my sleep apnea snoring would almost disappear with weight loss,” she said. “I was more concerned with other health issues to even think about it.”OSA is the most common type of sleep apnea.Other risk factors include age, being male, family history and genetics, heart or kidney failure, and drinking alcohol or smoking.
The most common sleep apnea treatment is the CPAP machine.
To prescribe GLP-1 medications specifically for OSA, Reddy said more clinical trials studying the effects of GLP-1 analogs on OSA are needed.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Popular weight loss drug could treat sleep apnea, company saysJustin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Baca lebih lajut »
Cybersecurity Firm Takes Down 250 Websites Selling Fake Weight-Loss and Diabetes DrugsBrandShield, a cybersecurity firm, has successfully shut down over 250 websites that were selling counterfeit versions of popular weight-loss and diabetes drugs in the GLP-1 class. The majority of these websites were related to GLP-1 medicines, which are used to treat metabolic conditions and also aid in weight loss.
Baca lebih lajut »
Drugmakers Spend Big on Weight Loss and Diabetes Treatment AdsCompanies spent more than $1 billion on ads for weight loss and diabetes medicines in 2023, up 51% from the prior year, according to new data. This demonstrates the rush to capture new customers after the success of drugs like Ozempic and Wegovy.
Baca lebih lajut »
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billionDrugmakers spent big on ads for weight loss and diabetes drugs such as Wegovy and Ozempic. Meanwhile, the FDA approved the first AI diagnostic tool for sepsis.
Baca lebih lajut »
Cognitive factors may influence attrition, weight loss, and weight maintenance.Specific cognitive factors are associated with attrition, weight loss, and maintenance, but are not usually addressed by the treatment of obesity
Baca lebih lajut »
Everything to Know About Weight Training for Weight Loss, According to ExpertsCertified personal trainer, Natascha Grief, shows you how to perfect your plank.
Baca lebih lajut »